Jul 2026· Frontiers in Bioscience· Vol 31 7, pp.
52994
· 0 citations· 37 references
Medicine
TL;DR
This integrated platform represents a promising preclinical strategy for treating ischemic stroke and has potential applications in other neuroinflammatory diseases, and suggests potential for future translation pending further validation.
Abstract
Background
Ischemic stroke is a major cause of death and disability, in which neuroinflammation exacerbates injury. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) offer therapeutic potential but face translational hurdles in scalable production, rapid systemic clearance, and inefficient targeted delivery.
Methods
We engineered an implantable alginate-microsphere system encapsulating EV-secreting MSCs and displaying the RGD-4C peptide (ACDCRGDCFC) on its surface. This platform functions as a bioreactor that sustains the release of functionalized EVs with enhanced targeting to the ischemic brain. Proteomics analyses compared EVs derived from 3D-microsphere cultures and conventional 2D cultures. Efficacy was evaluated in a mouse stroke model with intraperitoneal microsphere implantation, assessing biodistribution, neuroinflammation, microglial polarization, and recovery.
Results
The system sustained the release of targeted EVs, demonstrating proteomic enrichment of anti-inflammatory cargo. In vivo, the platform enhanced EV accumulation in the ischemic brain, reduced neuroinflammation, shifted microglia toward a reparative phenotype, and significantly improved neuronal survival and functional recovery.
Conclusion
This integrated platform represents a promising preclinical strategy for treating ischemic stroke and has potential applications in other neuroinflammatory diseases. This system circumvents the need for EV extraction and storage while eliminating the peak-and-trough kinetics of bolus injections, and suggests potential for future translation pending further validation.
BACKGROUND
Ischemic stroke is a leading cause of disability and mortality worldwide, with limited therapeutic options for long-term recovery. Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes have emerged as a promising cell-free therapy, but their efficacy is often constrained by poor homing efficiency...
Liver fibrosis remains a major unmet clinical challenge characterized by persistent activation of hepatic stellate cells (HSCs), chronic inflammatory remodeling, and impaired hepatocyte regeneration. Although mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics...
Fang-Hong Wang, Ke-Xiang Zhu, Xiao-Liang Zhu et al.· Frontiers in Bioengineering...· 0 citations
Ischemic stroke reperfusion injury is driven by oxidative stress and neuroinflammation, but current neuroprotective strategies suffer from poor targeting, limited functionality, and low blood‑-brain barrier (BBB) penetration. Herein, a multifunctional nanoplatform (RM@HPAN) is constructed: a hollow mesoporous Prussian...
Spinal cord injury (SCI) is a devastating neurological disorder characterized by excessive neuroinflammation and limited regenerative capacity. Here, we developed a reactive oxygen species (ROS)-responsive hydrogel for localized delivery of liposomal indole-3-propionic acid (IPA), a gut microbiota-derived metabolite wi...
Long-Yu Li, Yu-Hao Zhang, Zhi-Shuo Wang et al.· Materials Today Bio· 0 citations
Spinal cord injury (SCI) remains a devastating neurological disorder with few effective therapeutic interventions due to the poor intrinsic regenerative capacity of adult central nervous system neurons. Here, we identified miR-129-5p as a downstream effector of cAMP-response element binding protein (CREB) signaling tha...
Guang-Jin Gu, Han-Ming Zhu, Sheng-Ran Li et al.· Bioactive Materials· 0 citations
Spinal cord injury (SCI) leads to significant locomotor, sensory, and autonomic deficits and remains refractory to current therapies. Extracellular vesicles from mesenchymal stromal cells (MSC-EVs) are potential acellular therapeutic strategy for tissue regeneration, but rapid clearance and poor lesion retention limit...